Seelos Therapeutics to execute 1-for-16 reverse stock split

seekingalpha2024-09-25

Seelos Therapeutics (NASDAQ:SEEL) plans to implement a 1-for-16 reverse stock split of its outstanding shares of common stock on September 27, 2024. The reverse stock split is intended for the company...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2470254976?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2024-09-25 20:48","share_image_url":"https://static.laohu8.com/5a36db9d73b4222bc376d24ccc48c8a4","id":"2470254976","market":"us","top_or_hot":-1,"title":"Seelos Therapeutics to execute 1-for-16 reverse stock split","media":"seekingalpha","content":"<div>\n<p>Seelos Therapeutics (NASDAQ:SEEL) plans to implement a 1-for-16 reverse stock split of its outstanding shares of common stock on September 27, 2024. The reverse stock split is intended for the company...</p>\n\n<a href=\"https://seekingalpha.com/news/4153065-seelos-therapeutics-to-execute-1-for-16-reverse-stock-split\">Source Link</a>\n\n</div>\n","source":"seekingalpha","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Seelos Therapeutics to execute 1-for-16 reverse stock split</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nSeelos Therapeutics to execute 1-for-16 reverse stock split\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-09-25 20:48 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://seekingalpha.com/news/4153065-seelos-therapeutics-to-execute-1-for-16-reverse-stock-split><strong>seekingalpha</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Seelos Therapeutics (NASDAQ:SEEL) plans to implement a 1-for-16 reverse stock split of its outstanding shares of common stock on September 27, 2024. The reverse stock split is intended for the company...</p>\n\n<a href=\"https://seekingalpha.com/news/4153065-seelos-therapeutics-to-execute-1-for-16-reverse-stock-split\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SEEL","symbol_name":"Seelos Therapeutics, Inc.","start_time":0,"source_url":"https://seekingalpha.com/news/4153065-seelos-therapeutics-to-execute-1-for-16-reverse-stock-split","article_id":"2470254976","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2470254976","pubTimestamp":1727268495,"columns":[],"sourceInfo":{"source_id":"seekingalpha","name":"Seeking Alpha"},"weMediaInfo":null,"summary":"Seelos Therapeutics  plans to implement a 1-for-16 reverse stock split of its outstanding shares of common stock on September 27, 2024. The reverse stock split is intended for the company to regain compliance with the minimum bid price requirement of $1.00 per share of common stock for continued listing on the Nasdaq Capital Market. At the effective time of the split, every sixteen  issued and outstanding shares of the company's common stock will be combined automatically into one  share of its common stock without any change in the par value per share. The common stock will begin trading on a reverse stock split-adjusted basis at the opening of the market on September 27. The split will reduce the number of issued and outstanding shares of the company's common stock from approximately 9.2M to approximately 581 thousand. Shares of the firm gained over 6% in premarket trade.","collect":0,"end_time":0,"defaultTopTitle":"seekingalpha.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"SEEL":"Seelos Therapeutics, Inc.","BK4007":"制药"},"translate_title":"Seelos Therapeutics将执行16股1股的反向股票分割","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SEEL":0.9},"content_text":"Seelos Therapeutics (NASDAQ:SEEL) plans to implement a 1-for-16 reverse stock split of its outstanding shares of common stock on September 27, 2024. The reverse stock split is intended for the company to regain compliance with the minimum bid price requirement of $1.00 per share of common stock for continued listing on the Nasdaq Capital Market. At the effective time of the split, every sixteen (16) issued and outstanding shares of the company's common stock will be combined automatically into one (1) share of its common stock without any change in the par value per share. The common stock will begin trading on a reverse stock split-adjusted basis at the opening of the market on September 27. The split will reduce the number of issued and outstanding shares of the company's common stock from approximately 9.2M to approximately 581 thousand. Shares of the firm gained over 6% in premarket trade.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.30.0","shortVersion":"4.30.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2470254976"}